Sanofi announces changes to its Executive Committee
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
Subscribe To Our Newsletter & Stay Updated